2,3-Dihydroxypropyl oleate

2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.

Cross Reference

Introduction

To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate

PubChem Associated disorders and diseases

What pathways are associated with 2,3-Dihydroxypropyl oleate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2,3-Dihydroxypropyl oleate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 2,3-Dihydroxypropyl oleate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What genes are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2,3-Dihydroxypropyl oleate

Download all related citations
Per page 10 20 50 100 | Total 520
Authors Title Published Journal PubMed Link
López CA et al. Amylose folding under the influence of lipids. 2012 Carbohydr. Res. pmid:23128420
Pepe D et al. Decylglucoside-based microemulsions for cutaneous localization of lycopene and ascorbic acid. 2012 Int J Pharm pmid:22692080
Chong JY et al. High-throughput discovery of novel steric stabilizers for cubic lyotropic liquid crystal nanoparticle dispersions. 2012 Langmuir pmid:22630595
Kubicek J et al. Controlled in meso phase crystallization--a method for the structural investigation of membrane proteins. 2012 PLoS ONE pmid:22536388
Moebus K et al. Cubic phase-forming dry powders for controlled drug delivery on mucosal surfaces. 2012 J Control Release pmid:21963767
Kulkarni CV Lipid crystallization: from self-assembly to hierarchical and biological ordering. 2012 Nanoscale pmid:22899223
Su X et al. [Preparation and physiochemical properties of curcumin-loaded lipid cubic liquid crystalline nanoparticles]. 2012 Zhong Yao Cai pmid:22822677
Nilsson C et al. Characterization of oil-free and oil-loaded liquid-crystalline particles stabilized by negatively charged stabilizer citrem. 2012 Langmuir pmid:22831645
Yaghmur A et al. Self-assembled nanostructures of fully hydrated monoelaidin-elaidic acid and monoelaidin-oleic acid systems. 2012 Langmuir pmid:22690845
Kwon TK and Kim JC Monoolein cubic phase containing acidic proteinoid: pH-dependent release. 2011 Drug Dev Ind Pharm pmid:20528616
Pandit AA and Dash AK Surface-modified solid lipid nanoparticulate formulation for ifosfamide: development and characterization. 2011 Nanomedicine (Lond) pmid:22091968
Falkman P et al. Lyotropic lipid phases confined in cylindrical pores: structure and permeability. 2011 J Phys Chem B pmid:22007791
Lian R et al. Silymarin glyceryl monooleate/poloxamer 407 liquid crystalline matrices: physical characterization and enhanced oral bioavailability. 2011 AAPS PharmSciTech pmid:21948306
Montenegro L et al. In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain. 2011 Drug Dev Ind Pharm pmid:21204752
Rizwan SB et al. Preparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccines. 2011 Eur J Pharm Biopharm pmid:21237267
Kulkarni CV et al. Monoolein: a magic lipid? 2011 Phys Chem Chem Phys pmid:21183976
Achrai B et al. Solubilization of gabapentin into HII mesophases. 2011 J Phys Chem B pmid:21182317
Kwon TK and Kim JC Complex coacervation-controlled release from monoolein cubic phase containing silk fibroin and alginate. 2011 Biomacromolecules pmid:21190340
Angelov B et al. SAXS investigation of a cubic to a sponge (L3) phase transition in self-assembled lipid nanocarriers. 2011 Phys Chem Chem Phys pmid:21079857
Yuan L and Zheng YF A microdevice for the mixing of a highly viscous biosample with water/membrane protein solution using microchannel and centrifugation. 2011 J Lab Autom pmid:21609687